Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]-

Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]- Basic information
Product Name:Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]-
Synonyms:Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]-;(S)-YNT-3708
CAS:2923138-00-3
MF:C35H36N4O6S
MW:640.75
EINECS:
Product Categories:
Mol File:2923138-00-3.mol
Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]- Structure
Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]- Chemical Properties
density 1.351±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka8.361±0.40(predicted)
Safety Information
MSDS Information
Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]- Usage And Synthesis
Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]- Preparation Products And Raw materials
Tag:Benzeneacetamide, 3-methoxy-N-methyl-N-[(1S)-1,2,3,4-tetrahydro-7-[[[2-methoxy-5-[(1E)-3-oxo-3-(4-pyridinylamino)-1-propen-1-yl]phenyl]sulfonyl]amino]-1-naphthalenyl]-(2923138-00-3) Related Product Information
(2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanonehydrochloride Rocatinlimab N-(2-Methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea Orexin A (17-33) EMPA Vonlerolizumab